- Home » News and EventsPage 32
NEWS & EVENTS
Our newest offerings and capabilities. Recent investments in network capacity, new and expanded services and expertise. Upcoming conferences and events.
Catalent Biologics Adopts Berkeley Lights’ Beacon® Optofluidic Platform
Jul 10, 2018
SOMERSET, N.J. – July 10, 2018 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, a…
Catalent Signs Agreement to Acquire Juniper Pharmaceuticals, Inc.
Jul 3, 2018
The acquisition of Juniper is subject to certain customary closing conditions, including that a majority of Juniper’s shares are tendered into the offer, and is expected to close in the first quarter …
Catalent Biologics Appoints New General Manager for Madison, Wisconsin
Jun 26, 2018
Catalent Pharma Solutions today announced that Graham Brearley, Ph.D., has been appointed as General Manager of the company’s Madison, Wisconsin facility. SOMERSET, N.J. – June 26, 2018 — Catalent Pha…
Catalent Appoints Paul Hegwood as New President of Clinical Supply Services
Jun 13, 2018
Paul Hegwood as President of the company’s Clinical Supply Services business. SOMERSET, N.J. – June 13, 2018 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies …
Biological Drug Development & Delivery at Catalent Institute / JLABS Symposium
Jun 7, 2018
The Catalent Applied Drug Delivery Institute today announced that it is to hold a one-day symposium in partnership with Johnson & Johnson Innovation, JLABS, entitled “Advances in Drug Development and …
Catalent Biologics Supports New Methamphetamine Treatment
May 31, 2018
Catalent Biologics Supports New Methamphetamine Treatment. SOMERSET, N.J. – May 31, 2018 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solu…
Catalent Completes $5.5 Million Expansion at Kansas City
May 17, 2018
SOMERSET, N.J. – May 17, 2018 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, to…
Catalent Biologics and Valerius Biopharma to Collaborate on Biosimilars
May 14, 2018
Catalent Biologics and Valerius Biopharma to Collaborate on Biosimilars. Somerset, N.J. – May 14, 2018 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and de…
Biohaven announces Expanded Access Program for Patients with ALS
May 9, 2018
Catalent’s partner, Biohaven, announces it has Initiated Expanded Access Program for Sublingual BHV-0223 ZYDIS® Orally Dissolving Tablets for Patients with Amyotrophic Lateral Sclerosis (ALS)
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.